Conant Optical (2276 HKG): 1H26 Revenue and Margins Expand; XR Lenses Growth Story Slowly Unfolding
In 1H26, Shanghai Conant reported revenue rise of 8% YoY to RMB 1.2B. Demand outlook, expansion plans, R&D initiatives and margin strength offer a...
109 Views
Primer: Shanghai Conant Optical (2276 HK) - Aug 2026
Shanghai Conant Optical is a leading Chinese manufacturer of resin spectacle lenses, well-positioned to capitalize on the growing domestic and...
105 Views
Conant Optical (2276 HKG): Revenue Rise, Margins Expand in 2025; XR Lenses To Pave Way For Future
​Shanghai Conant Optical (2276 HK) sees revenue rise in 2025, driven by growth in multifunctional and standardized lens. Expanding gross margins...
127 Views
Conant Optical (2276 HK) Placement: Robust Outlook, Margin Strength Makes Growth Optics Clearer
​Shanghai Conant Optical (2276 HK) places 27M shares at HK$52/share for XR production line, R&D, and working capital. The placement is an opportune...
283 Views
APAC Healthcare Weekly (August 16) – Akeso, Fosun Pharma, CSPC Pharma, Daiichi Sankyo, Peptidream
Akeso’s ivonescimab and Daiichi Sankyo’s Enhertu got additional indications approvals in China. CSPC Pharma’s mpox mRNA vaccine candidate got FDA...
107 Views